Magenta Therapeutics, Inc.·4

Feb 12, 5:07 PM ET

GARDNER JASON 4

4 · Magenta Therapeutics, Inc. · Filed Feb 12, 2020

Insider Transaction Report

Form 4
Period: 2020-02-10
GARDNER JASON
DirectorSee Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-02-10+275,000275,000 total
    Exercise: $12.28Exp: 2030-02-09Common Stock (275,000 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on January 1, 2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION